Article
Proteogenomic characterization of difficult-to-treat breast cancer with tumor cells enriched through laser microdissection.
Breast cancer research : BCR - 14 May 2024
Raj-Kumar Praveen-Kumar, Lin Xiaoying, Liu Tao, Sturtz Lori A, Gritsenko Marina A, Petyuk Vladislav A, Sagendorf Tyler J, Deyarmin Brenda, Liu Jianfang, Praveen-Kumar Anupama, Wang Guisong, McDermott Jason E, Shukla Anil K, Moore Ronald J, Monroe Matthew E, Webb-Robertson Bobbie-Jo M, Hooke Jeffrey A, Fantacone-Campbell Leigh, Mostoller Brad, Kvecher Leonid, Kane Jennifer, Melley Jennifer, Somiari Stella, Soon-Shiong Patrick, Smith Richard D, Mural Richard J, Rodland Karin D, Shriver Craig D, Kovatich Albert J, Hu Hai
Abstract excerpt
BACKGROUND: Breast cancer (BC) is the most commonly diagnosed cancer and the leading cause of cancer death among women globally. Despite advances, there is considerable variation in clinical outcomes for patients with non-luminal A tumors, classified as difficult-to-treat breast cancers (DTBC). This study aims to delineate the proteogenomic landscape of DTBC tumors compared to luminal A (LumA) tumors. METHODS: We...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
